Juan Carlos Quevedo-Abeledo

Author

Hospital Universitario de Gran Canaria Doctor Negrín ORCID

Also Known As

J. C. Quevedo-Abeledo, J.C. Quevedo Abeledo, J.C. Quevedo-Abeledo, JC Quevedo-Abeledo, JUAN C. QUEVEDO-ABELEDO, Juan C Quevedo-Abeledo, Juan C. Quevedo-Abeledo, Juan C. Quevedo‐Abeledo, Juan Carlos Quevedo Abeledo, Juan Carlos Quevedo-Abeledo

103

Publications

783

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de Gran Canaria Doctor Negrín Hospital Universitario de Canarias Instituto de Investigación Marqués de Valdecilla Universidad de Cantabria University of the Witwatersrand

About

Juan Carlos Quevedo-Abeledo is an author at Hospital Universitario de Gran Canaria Doctor Negrín specializing in medicine, rheumatology, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	113
2	Public Health	2	2	47
3	Nursing	1	1	22
4	Epidemiology	1	1	16
5	Health Policy	1	1	31

Juan Carlos Quevedo-Abeledo

Publications

565

Citations

H-Index

Page 1

	Year	Citations
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis Fernanda Genre, Javier Rueda‐Gotor, Sara Remuzgo‐Martínez, Scientific Reports	2020	85
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis Hiurma Sánchez‐Pérez, Juan Carlos Quevedo-Abeledo, Laura de Armas‐Rillo, Lara D. Veeken	2020	46
Two-year adherence to treatment and associated factors in a fracture liaison service in Spain Antonio Naranjo, Soledad Ojeda-Bruno, A. Bilbao-Cantarero, Osteoporosis International Skeletal TraumaFracture Liaison ServiceHealth PolicyFracture DiagnosticsOperative Treatment	2015	31
Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus Juan Carlos Quevedo-Abeledo, Hiurma Sánchez‐Pérez, Beatriz Tejera‐Segura, The Journal of Rheumatology	2020	25
Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus Hiurma Sánchez‐Pérez, Juan Carlos Quevedo-Abeledo, Beatriz Tejera‐Segura, Therapeutic Advances in Musculoskeletal Disease	2020	24
Results of a Model of Secondary Prevention for Osteoporotic Fracture Coordinated by Rheumatology and Focused on the Nurse and Primary Care Physicians Antonio Naranjo, Soledad Ojeda-Bruno, Ana Bilbao Cantarero, Reumatología Clínica (English Edition) NursingRheumatologyPrimary Care PhysiciansBone DiseasePreventive Medicine	2014	22
Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk Iván Ferraz‐Amaro, Alfonso Corrales, Juan Carlos Quevedo-Abeledo, Arthritis Research & Therapy	2021	22
Differences in Capacity of High‐Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis Juan Carlos Quevedo-Abeledo, Hiurma Sánchez‐Pérez, Beatriz Tejera‐Segura, Arthritis Care & Research	2020	21
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis Sara Remuzgo‐Martínez, Javier Rueda‐Gotor, Verónica Pulito‐Cueto, Frontiers in Immunology	2022	21
Patient-acceptable Symptom State as an Outcome Measure in the Daily Care of Patients with Ankylosing Spondylitis Carlos Rodríguez‐Lozano, MARÍA-ÁNGELES GANTES, Beatríz González, The Journal of Rheumatology	2012	20

Page 1